Conmed (CNMD) Interest Expenses (2010 - 2026)

Conmed's Interest Expenses history runs 17 years deep, the most recent figure standing at $40.6 million for Q1 2026.

• Quarterly Interest Expenses rose 3.86% year-over-year to $40.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.6 million (up 3.86% YoY) and the FY2025 annual result came in at $39.0 million, down 24.53% from the prior year.
• Interest Expenses was $40.6 million for Q1 2026 at Conmed, up from $30.7 million in the prior quarter.
• Across five years, Interest Expenses topped out at $40.6 million in Q1 2026 and bottomed at -$30.3 million in Q4 2023.
• A 5-year average of $29.5 million and a median of $36.4 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses tumbled 420.57% — and 2025, when it soared 627.79%.
• Conmed's Interest Expenses stood at $9.4 million in 2022, then tumbled by 420.57% to -$30.3 million in 2023, then jumped by 113.92% to $4.2 million in 2024, then surged by 627.79% to $30.7 million in 2025, then surged by 32.42% to $40.6 million in 2026.
• Business Quant data shows CNMD's Interest Expenses at $40.6 million in Q1 2026, $30.7 million in Q4 2025, and $39.2 million in Q3 2025.